ObjectivesThe aim of our study was to evaluate the effectiveness and tolerability of perampanel (PER) as first add-on and as second line monotherapy in subjects with childhood absence epilepsy. MethodsOur sample consisted of 20 patients with childhood absence epilepsy. aged between 8 and 10. already in therapy with a first antiseizure medication with incomplete seizure control. https://cosmeticssquadets.shop/product-category/medication-management/